Clinical Report: Development of Innovative Embolization Materials for T2EL

Overview

This study introduces the Thrombin-Coated Controllable Coil (TCC) as a novel embolization material aimed at preventing Type II Endoleak (T2EL) after Endovascular Aneurysm Repair (EVAR) for abdominal aortic aneurysm (AAA). TCC demonstrated significant improvements in coagulation efficiency and effectively prevented T2EL in a minipig model, highlighting its potential as a next-generation treatment option.

Background

Abdominal aortic aneurysm (AAA) is a critical vascular condition often treated with EVAR, yet complications such as T2EL pose significant risks. The incidence of T2EL can range from 10% to 44%, with persistent cases leading to serious complications like aneurysm sac enlargement and rupture. Effective strategies to mitigate T2EL during EVAR are essential for improving patient outcomes.

Data Highlights

Key Findings

• TCC showed a uniform thrombin coating and effective thrombin loading.
• Coagulation time was significantly shortened with TCC compared to IDC and control groups.
• TCC promoted apoptosis of vascular smooth muscle cells (VSMCs) while minimally affecting vascular endothelial cells (VECs).
• In vivo, TCC effectively prevented T2EL and achieved complete thrombosis within the aneurysm.
• Transcriptomic analysis revealed 161 differentially expressed genes associated with TCC treatment.

Clinical Implications

The introduction of TCC may provide a safer and more effective option for preventing T2EL during EVAR procedures. Its ability to enhance coagulation and promote thrombosis could lead to improved patient outcomes and reduced need for re-intervention.

Conclusion

TCC represents a promising advancement in embolization materials for preventing T2EL after EVAR, demonstrating both efficacy and safety in preclinical models. Further clinical studies are warranted to validate these findings.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. BJS (British Journal of Surgery), 2024 -- Results of a Prospective Multicenter Trial on Endovascular Repair of the Aortic Arch Using a Standard Modular Inner Branched Stent-Graft: An IDEAL 2a Study
4. European Society for Vascular Surgery (ESVS), 2024 -- Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms
5. CIRSE, 2024 -- Standards of Practice on Management of Endoleaks Following Endovascular Aneurysm Repair
6. Approaches and outcomes in the repair of true visceral and renal artery aneurysms
7. Five-year follow-up of randomized clinical trial for pre-emptive inferior mesenteric artery embolization during endovascular aneurysm repair
8. Comparing Sac Embolization and Inferior Mesenteric Artery Embolization in Preventing Type II Endoleaks Post-EVAR
9. Preemptive aneurysm sac embolization for infrarenal endovascular aneurysm repair
10. Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms☆
11. CIRSE Standards of Practice on Management of Endoleaks Following Endovascular Aneurysm Repair
12. Endovascular aortic repair with sac embolization for the prevention of type II endoleaks (the EVAR-SE study): study protocol for a randomized controlled multicentre study in Germany - PMC
13. Translumbar type II endoleak embolization with a new liquid iodinated polyvinyl alcohol polymer: Case series and review of current literature - PMC
14. Initial Clinical Experience With AneuFix Injectable Biocompatible Elastomer for Translumbar Embolization of Type 2 Endoleaks - PMC
15. Treatment of type II endoleaks after endovascular repair of abdominal aortic aneurysms: translumbar puncture and injection of thrombin into the aneurysm sac - PubMed